Incoming medical students’ knowledge of and attitudes toward people with substance use disorders: Implications for curricular training

References

• Drug Enforcement Administration. Drug Enforcement Administration National Drug Threat Assessment. Washington, DC: DEA; 2019. https://www.dea.gov/sites/default/files/2020-01/2019-NDTA-final-01-14-2020_Low_Web-DIR-007-20_2019.pdf.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2018 National Survey on Drug Use and Health. Rockville, MD: SAMHSA; 2019.
   Google Scholar
• Cherpitel CJ, Ye Y. Drug use and problem drinking associated with primary care and emergency room utilization in the US general population: data from the 2005 national alcohol survey. Drug Alcohol Depend. 2008;97(3):226–230.
   PubMed Web of Science ®Google Scholar
• Allespach H, Stahl KD. "Dread to treat" patients in cardiac surgery: global strategies for interacting with cardiothoracic patients with substance use disorders. J Card Surg. 2019;34(12):1427–1429.
   PubMed Web of Science ®Google Scholar
• Scott CK, Grella CE, Dennis ML, Nicholson L. Linking individuals with substance use disorders (SUDs) in primary care to SUD treatment: the Recovery Management Checkups-Primary Care (RMC-PC) Pilot Study. J Behav Health Serv Res. 2018;45(2):160–173.
   PubMed Web of Science ®Google Scholar
• Hawk K, D'Onofrio G. Emergency department screening and interventions for substance use disorders. Addict Sci Clin Pract. 2018;13(1):18.
   PubMedGoogle Scholar
• Dahan A, Aarts L, Smith TW. Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology. 2010;112(1):226–238.
   PubMed Web of Science ®Google Scholar
• Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012;367(2):146–155.
   PubMed Web of Science ®Google Scholar
• Walley AY, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346(jan30 5):f174.
   PubMed Web of Science ®Google Scholar
• Avetian GK, Fiuty P, Mazzella S, Koppa D, Heye V, Hebbar P. Use of naloxone nasal spray 4 mg in the community setting: a survey of use by community organizations. Curr Med Res Opin. 2018;34(4):573–576.
   PubMed Web of Science ®Google Scholar
• Franko T, Longyhore D. Naloxone coverage remains a barrier to use. J Am Pharm Assoc. 2017;57(6):740.
   Google Scholar
• Winstanley EL, Clark A, Feinberg J, Wilder CM. Barriers to implementation of opioid overdose prevention programs in Ohio. Subst Abus. 2016;37(1):42–46.
   PubMed Web of Science ®Google Scholar
• Morton KJ, Harrand B, Floyd CC, et al. Pharmacy-based statewide naloxone distribution: a novel “top-down, bottom-up” approach. J Am Pharm Assoc. 2017;57(2S):S99–S106.e5.
   Google Scholar
• Gatewood AK, Van Wert MJ, Andrada AP, Surkan PJ. Academic physicians' and medical students' perceived barriers toward bystander administered naloxone as an overdose prevention strategy. Addict Behav. 2016;61:40–46.
   PubMed Web of Science ®Google Scholar
• Barbour K, McQuade M, Somasundaram S, Chakravarthy B. Emergency physician resistance to a take-home naloxone program led by community harm reductionists. Am J Emerg Med. 2018;36(11):2110–2112.
   PubMed Web of Science ®Google Scholar
• Peckham AM, Niculete ME, Steinberg H, Boggs DL. A survey of prescribers' attitudes, knowledge, comfort, and fear of consequences related to an opioid overdose education and naloxone distribution program. J Public Health Manag Pract. 2018;24(4):310–317.
   PubMed Web of Science ®Google Scholar
• Freeman PR, Goodin A, Troske S, Strahl A, Fallin A, Green TC. Pharmacists' role in opioid overdose: Kentucky pharmacists' willingness to participate in naloxone dispensing. J Am Pharm Assoc. 2017;57(2S):S28–S33.
   Google Scholar
• Thornton JD, Lyvers E, Scott VG, Dwibedi N. Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia. J Am Pharm Assoc. 2017;57(2S):S12–S18.e4.
   Google Scholar
• Jones CM, Lurie PG, Compton WM. Increase in naloxone prescriptions dispensed in US retail pharmacies since 2013. Am J Public Health. 2016;106(4):689–690.
   PubMed Web of Science ®Google Scholar
• Jack HE, Warren KE, Sundaram S, et al. Making naloxone rescue part of basic life support training for medical students. Santen S, ed. AEM Educ Train. 2018;2(2):174–177.
   PubMedGoogle Scholar
• Cox BM, Cote TE, Lucki I. Addressing the opioid crisis: medical student instruction in opioid drug pharmacology, pain management, and substance use disorders. J Pharmacol Exp Ther. 2019;371(2):500–506.
   PubMed Web of Science ®Google Scholar
• Kothari D, Gourevitch MN, Lee JD, et al. Undergraduate medical education in substance abuse: a review of the quality of the literature. Acad Med. 2011;86(1):98–112.
   PubMed Web of Science ®Google Scholar
• Cape G, Hannah A, Sellman D. A longitudinal evaluation of medical student knowledge, skills and attitudes to alcohol and drugs. Addiction. 2006;101(6):841–849.
   PubMed Web of Science ®Google Scholar
• Berland N, Fox A, Tofighi B, Hanley K. Opioid overdose prevention training with naloxone, an adjunct to basic life support training for first-year medical students. Subst Abus. 2017;38(2):123–128.
   PubMed Web of Science ®Google Scholar
• Berland N, Lugassy D, Fox A, et al. Use of online opioid overdose prevention training for first-year medical students: a comparative analysis of online versus in-person training. Subst Abus. 2019;0(0):1–7.
   Google Scholar
• Tobin H, Klimas J, Barry T, Egan M, Bury G. Opiate use disorders and overdose: medical students' experiences, satisfaction with learning, and attitudes toward community naloxone provision. Addict Behav. 2018;86:61–65.
   PubMed Web of Science ®Google Scholar
• Compton WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription-opioid use and heroin use. Longo DL, ed. N Engl J Med. 2016;374(2):154–163.
   PubMed Web of Science ®Google Scholar
• Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC: National Academies Press; 2011.
   Google Scholar
• Williams AV, Strang J, Marsden J. Development of Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales for take-home naloxone training evaluation. Drug Alcohol Depend. 2013;132(1–2):383–386.
   PubMed Web of Science ®Google Scholar
• Winograd RP, Werner KB, Green L, Phillips S, Armbruster J, Paul R. Concerns that an opioid antidote could “make things worse”: profiles of risk compensation beliefs using the Naloxone-Related Risk Compensation Beliefs (NaRRC-B) scale. Subst Abus. 2020;41(2):245–251.
   PubMed Web of Science ®Google Scholar
• Association of American Medical Colleges. Matriculating Student Questionnaire. 2019. www.aamc.org/data/msq. Accessed September 18, 2020.
   Google Scholar
• Lott DC, Rhodes J. Opioid overdose and naloxone education in a substance use disorder treatment program. Am J Addict. 2016;25(3):221–226.
   PubMed Web of Science ®Google Scholar
• Stover AN, Grogg K, Patel J, Thornton D, Dwibedi N. Opioid overdose knowledge among college students in a high overdose death state. J Hum Behav Soc Environ. 2019;29(7):887–896.
   PubMed Web of Science ®Google Scholar
• Gilchrist G, Moskalewicz J, Slezakova S, et al. Staff regard towards working with substance users: a European multi-centre study. Addiction. 2011;106(6):1114–1125.
   PubMed Web of Science ®Google Scholar
• Meltzer EC, Suppes A, Burns S, et al. Stigmatization of substance use disorders among internal medicine residents. Subst Abus. 2013;34(4):356–362.
   PubMed Web of Science ®Google Scholar
• Jones JD, Campbell A, Metz VE, Comer SD. No evidence of compensatory drug use risk behavior among heroin users after receiving take-home naloxone. Addict Behav. 2017;71:104–106.
   PubMed Web of Science ®Google Scholar
• Kim HK, Nelson LS. Reducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review. Expert Opin Drug Saf. 2015;14(7):1137–1146.
   PubMed Web of Science ®Google Scholar
• Bazazi AR, Zaller ND, Fu JJ, Rich JD. Preventing opiate overdose deaths: examining objections to take-home naloxone. J Health Care Poor Underserved. 2010;21(4):1108–1113.
   PubMed Web of Science ®Google Scholar